SEC Filing Summary: Athira Pharma, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Athira Pharma, Inc. (not Leonabio, Inc.) on August 1, 2024. The report serves to disclose the Company's financial results for the quarter ended June 30, 2024, as detailed in a press release furnished as Exhibit 99.1. The Company is an emerging growth company incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol ATHA.
Key Financial Metrics
The provided filing text acts as a cover document and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
No specific material changes versus the prior comparable period are quantified in this document. The filing indicates that the Company has issued a press release reporting Q2 2024 results, but the specific variances or trends are not described in the 8-K text itself.
Guidance, Outlook, and Risks
- Disclosure Channels: The Company utilizes its website, investor relations portal, and social media platforms (X, LinkedIn, Instagram, Facebook) to disseminate material information regarding product candidates and other matters.
- Regulation FD: The filing includes a Regulation FD disclosure statement, noting that information released through these channels may be deemed material.
- Outlook: No specific forward-looking guidance or management commentary is present in the 8-K text; investors are directed to the press release for details.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the Exhibit 99.1 press release referenced in this filing.
- Confirm the Company's name is Athira Pharma, Inc. (the input metadata incorrectly listed Leonabio, Inc.).
- Review the Company's social media channels and investor relations website for any additional material updates regarding product candidates.
- Check the Nasdaq listing status and ticker symbol ATHA for any trading halts or announcements coinciding with the August 1, 2024 date.